Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Envoy Medical has achieved successful activation of all first-stage participants in its pivotal clinical trial for the fully implanted Acclaim® cochlear implant as of May/June 2025. The company expects to expand into the final stage of this pivotal study later in 2025. The Esteem® active middle ear implant remains FDA-approved and commercially available in the US since 2010.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Envoy Medical, Inc..